Human endogenous retroviruses: Transposable elements with potential?

Clinical and Experimental Immunology

Volumn 138, Issue 1, 2004, Pages 1-9

  Nelson, P N ^a   Hooley, P ^a   Roden, D ^a   Ejtehadi, H Davari ^a   Rylance, P ^b   Warren, P ^a   Martin, J ^a   Murray, P G ^a  

^a UNIVERSITY OF WOLVERHAMPTON   (United Kingdom)

^b NEW CROSS HOSPITAL   (United Kingdom)

Author keywords

Autoimmunity; Human endogenous retroviruses; Molecular mimicry; Superantigens; Transposable elements

Indexed keywords

REPETITIVE DNA; SUPERANTIGEN;

AUTOIMMUNITY; DNA INTEGRATION; GERM LINE; HUMAN; HUMAN ENDOGENOUS RETROVIRUS; HUMAN GENOME; LONG INTERSPERSED ELEMENT; LONG TERMINAL REPEAT; MODULATION; MOLECULAR EVOLUTION; MOLECULAR MIMICRY; NONHUMAN; NUCLEOTIDE REPEAT; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RETROPOSON; RETROVIRUS; RETROVIRUS INFECTION; REVIEW; SHORT INTERSPERSED ELEMENT; TRANSPOSON; VIRUS CLASSIFICATION;

DNA TRANSPOSABLE ELEMENTS; DNA, VIRAL; ENDOGENOUS RETROVIRUSES; EVOLUTION, MOLECULAR; GENOME, HUMAN; HUMANS; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; RETROVIRIDAE INFECTIONS; SHORT INTERSPERSED NUCLEOTIDE ELEMENTS; SUPERANTIGENS; TERMINAL REPEAT SEQUENCES; VIRUS INTEGRATION;

EID: 4644291462     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2004.02592.x     Document Type: Review

References (79)

1. Knipe DM, Howley PM, eds. Fields virology, 4th edn. Philadelphia USA: Lippincott, Williams & Wilkins, 2001.
2. Griffiths DJ. Endogenous rretroviruses in the human genome sequence. Genome Biol 2001; 2:1017.1-1017.5.
3. Lower R, Lower J, Kurth R. The viruses in all of us: characteristics and biological significance of human endogenous retrovirus sequences. Proc Natl Acad Sci USA 1996; 93:5177-84.
4. Pennisi E. Gene counters struggle to get the right answer. Science 2003; 301:1040-1.
5. International Human Genome Sequencing Consortium. Initial sequencing and analysis of the human genome. Nature 2001; 409:860-921.
6. Mouse Genome Sequencing Consortium. Initial sequencing and comparative analysis of the mouse genome. Nature 2002; 420:520-62.
7. Nelson PN, Carnegie PR, Martin J et al. Demystified. Human endogenous retroviruses. J Clin Pathol Mol Pathol 2003; 56:11-8.
8. Larsson E, Andersson G. Beneficial role of human endogenous retroviruses: facts and hypotheses. Scand J Immunol 1998; 48:329-38.
9. Blond JL, Lavillette D, Cheynet V et al. An envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptor. J Virol 2000; 74:3321-9.
10. Perl A. Role of endogenous retroviruses in autoimmune diseases. Rheum Dis Clin North Am 2003; 29:123-43.
11. Wang-Johanning F, Frost AR, Jian B, Epp L, Lu DW, Johanning GL. Quantitation of HERV-K env gene expression and splicing in human breast cancer. Oncogene 2003; 22:1528-35.
12. Sauter M, Schommer S, Kremmer E et al. Human endogenous retrovirus K10: expression of gag protein and detection of antibodies in patients with seminomas. J Virol 1995; 69:414-21.
13. Jeffries AJ, Wilson V, Thein SL. Individual specific 'fingerprints' of human DNA. Nature 1985; 316:76-9.
14. Smit AF, Toth G, Riggs AD, Jurka J. Ancestral mammalian wide subfamilies of LINE-1 repetitive sequences. J Mol Biol 1995; 246:401-17.
15. Weiner AM. SINEs and LINEs: the art of biting the hand that feeds you. Curr Opin Cell Biol 2002; 14:343-50.
16. Ovchinnikov I, Rubia A, Swergold GD. Tracing the LINEs of human evolution. Proc Natl Acad Sci USA 2002; 99:10522-7.
17. Smit AFA. The origin of interspersed repeats in the human genome. Curr Opin Genet Dev 1996; 6:743-8.
18. Greally JM. Short interspersed transposable elements (SINEs) are excluded from imprinted regions in the human genome. Proc Natl Acad Sci USA 2002; 99:327-32.
19. Deininger PL, Batzer MA. Mammalian retroelements. Genome Res 2002; 12:1455-65.
20. Jurka J. Sequence patterns indicate an enzymatic involvement in integration of mammalian retroposons. Proc Natl Acad Sci USA 1997; 94:1872-7.
21. Schmid CW. Does SINE evolution preclude Alu function? Nucl Acids Res 1998; 26:4541-50.
22. Gifford R, Tristem M. The evolution, distribution and diversity of endogenous retroviruses. Virus Genes 2003; 26:291-315.
23. Robertson HM, Lampe DJ. Recent horizontal transfer of a mariner transposable element among and between Diptera and Neuroptera. Mol Biol Evol 1995; 12:850-62.
24. Hughes JF, Coffin JM. A novel endogenous retrovirus related element in the human genome resembles a DNA transposon: evidence for an evolutionary link? Genomics 2002; 80:453-5.
25. Pavlicek A, Paces J, Elleder D, Hejnar J. Processed pseudogenes of human endogenous retrovirus generated by LINEs; their integration, stability and distribution. Genome Res 2002; 12:391-9.
26. Brosius J. Genomes were forged by massive bombardments with retroelements and retrosequences. Genetika 1999; 107:209-38.
27. Li WH, Gu Z, Wang H, Nekrutenko A. Evolutionary analyses of the human genome. Nature 2001; 409:847-9.
28. Ostertag EM, Kazazian HH. Biology of mammalian L1 retrotransposons. Ann Rev Genet 2001; 35:501-38.
29. Deininger PL, Batzer MA. Alu repeats and human disease. Mol Genet Metab 1999; 67:183-93.
30. Bieda K, Hoffman Boller K. Phenotypic heterogeneity of human endogenous retrovirus particles produced by teratocarcinoma cell lines. J Gen Virol 2001; 82:591-6.
31. Nelson PN, Astley JS, Warren P. Monoclonal antibodies, the generation nd application of 'tools of the trade' within biomedical science. In: Crocker J, Murray PG, eds. Molecular biology in cellular pathology. Chichester: John Wiley & Sons Ltd, 2003, ch.16:329-49.
32. Smith K, Sampath S, Richards Warren P, Nelson PN, Greenman J. Selection and characterisation of phage antibodies to HERV-K. Immunology 2003; 110:S79.
33. Ejtehadi HD, Ali HA, Serhan E, Bowman S, Nelson PN. The potential role of human endogenous retrovirus K10 in pathogenesis of rheumatoid arthritis. Immunology 2002; 107:S109.
34. Nelson PN, Lever AML, Smith S et al. Molecular investigations implicate human endogenous retroviruses as mediators of anti-retroviral antibodies in autoimmune rheumatic diseases. Immun Invest 1999; 28:277-89.
35. Taruscio D, Floridia G, Zoraqi GK, Mantovani A, Falbo V. Organisation and integration sites in the human genome of endogenous retroviral sequences belonging to the HERV-E families. Mamm Genome 2002; 13:216-22.
36. Kidwell MG, Lisch D. Transposable elements as sources of variation in animals and plants. Proc Natl Acad Sci USA 1997; 94:7704-11.
37. Landry JR, Rouhi A, Medstrand P, Mager DL. The opitz syndrome gene mid1 is transcribed from a human endogenous retroviral promoter. Mol Biol Evol 2002; 19:1934-42.
38. Ling J, Pi W, Bollag R et al. The solitary long terminal repeats of ERV9 edogenous retrovirus are conserved during primate evolution and possess enhancer activities in embryonic and hematopoietic cells. J Virol 2002; 76:2410-23.
39. King Jordan I, Rogozin IB, Glazko GV, Koonin EV. Origin of a substantial fraction of human regulatory sequences from transposable elements. Trends Genet 2003; 19:68-72.
40. Speek M. Antisense promoter of human L1 retrotransposon drives transcription of adjacent cellular genes. Mol Cell Biol 2001; 21:1973-85.
41. Bailey JA, Carrel L, Chakravarti A, Eichler EE. Molecular evidence for a relationship between LINE-1 elements and X chromosome inactivation: the Lyon repeat hypothesis. Proc Natl Acad Sci USA 2000; 97:6634-9.
42. Sundberg EJ, Li Y, Mariuzza RA. So many ways of getting in the way: diversity in the molecular architecture of superantigen-dependent T-cell signaling complexes. Curr Opin Immunol 2002; 14:36-44.
43. Schafer R, Sheil JM. Superantigens and their role in infectious disease. Adv Pediatric Infect Dis 1995; 10:369-90.
44. Cameron SB, Nawijn MC, Kum WW, Savelkoul HF, Chow AW. Regulation of helper T cell responses to staphylococcal superantigens. Eur Cytokine Netw 2002; 12:210-22.
45. + T and B lymphocyte homeostasis. Immunobiology 2000, 202.
46. Paliard X, West SG, Lafferty JA et al. Evidence for the effects of a superantigen in rheumatoid arthritis. Science 1991; 253:325-9.
47. Furukawa F, Iwasaki-Inuzuka K, Takigawa M, Matisushita K. Selective expansion of T cells expressing V beta 8 and V beta 13 in skin lesions of patients with chronic cutaneous lupus erythematosus. J Dermatol 1999; 23:670-6.
48. Conrad B, Weissmahr RN, Boni J, Arcari R, Schupbach J, Mach B. A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes. Cell 1997; 90:303-113.
49. Woodland DL. Immunity and retroviral superantigens in humans. Trends Immunol 2002; 23:57-8.
50. Choi Y, Kappler JW, Marrack P. A superantigen encoded in the open reading frame of the 3′ long terminal repeat of mouse mammary tumour virus. Nature 1991; 350:203-7.
51. Sutkowski N, Palkama T, Ciurli C, Sekaly RP, Thorley-Lawson DA, Huber BT. An Epstein-Barr-virus-associated superantigen. J Exp Med 1996; 184:971-80.
52. Sutkowski N, Conrad B, Thorley-Lawson DA, Huber BT. Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen. Immunity 2001; 15:579-90.
53. Incaprera M, Rindi L, Bazzichi A, Garzelli C. Potential role of the Epstein-Barr virus in systemic lupus erythematosus autoimmunity. Clin Exp Rheumatol 1998; 16:289-94.
54. Levin LI, Munger KL, Rubertone MV et al. Multiple sclerosis and Epstein-Barr virus. JAMA 2003; 289:1533-6.
55. Kwun HJ, Han HJ, Lee WJ, Kim HS, Jang KL. Transactivation of the human endogenous retrovirus K long terminal repeat by herpes simplex irus type 1 immediate early protein 0. Virus Res 2002; 86:93-100.
56. Lee WJ, Kwun HJ, Kim HS, Jang KL. Activation of the human endogenous retrovirus W long terminal repeat by herpes simplex virus type 1 immediate early protein 1. Mol Cells 2003; 15:75-80.
57. Stauffer Y, Marguerat S, Meylan F et al. Interferon-alpha-induced endogenous superantigen: a model linking environment and autoimmunity. Immunity 2001; 15:591-601.
58. Hugin AW, Tang Y, Vacchio MS et al. Is a superantigen involved in the pathogenesis of MAIDS? In: Tomonari K, ed. Viral superantigens. FL, USA: CRC Press Inc., 1995:207-18.
59. Sharp TV, Boshoff C. Kaposi's sarcoma-associated herpesvirus: from cell biology to pathogenesis. IUBMB Life 2000; 49:97-104.
60. Eliopoulos AG, Gallagher NJ, Blake SM, Dawson CW, Young LS. Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production. J Biol Chem 1999; 274:16085-96.
61. Arvanitakis L, Yaseen N, Sharma S. Latent membrane protein-1 induces cyclin D2 expression, pRb hyperphosphorylation, and loss of TGF-beta 1-mediated growth inhibition in EBV-positive B cells. J Immunol 1995; 155:1047-56.
62. Levin MC, Lee SM, Kalume F et al. Autoimmunity due to molecular mimicry as a cause of neurological disease. Nat Med 2002; 8:509-13.
63. Oldstone M. Molecular mimicry and immune mediated disease. FASEB J 1998; 12:1255-65.
64. Talal N, Dauphinee MJ, Dany M, Alexander SS, Hart DJ, Garry RF. Detection of serum antibodies to retroviral proteins in patients with primary Sjögren's syndrome (autoimmune exocrinopathy). Arth Rheum 1990; 33:774-81.
65. Talal N, Garry RF, Schur PH et al. A conserved idiotype and antibodies to retroviral proteins in systemic lupus erythematosus. J Clin Invest 1990; 85:1866-71.
66. Nelson PN, Lever AML, Bruckner FE, Isenberg DA, Kessaris N, Hay FC. Polymerase chain reaction fails to incriminate exogenous retroviruses HTLV-I and HIV-1 in rheumatological diseases although a minority of sera cross-reacts with retroviral antigens. Ann Rheum Dis 1994; 53:749-54.
67. Nelson PN, Bowman SJ, Hay FC, Lanchbury JS, Panayi GS, Lever AML. Absence of exogenous retrovirus in Felty's syndrome. Br J Rheumatol 1995; 34:185-7.
68. Brookes SM, Pandolfino YA, Mitchell TJ et al. The immune response to and expression of cross-reactive retroviral Gag sequences in autoimmune disease. Br J Rheumatol 1992; 31:735-42.
69. Banki K, Hurley ME, Ablonczy E et al. Human T-cell lymphotropic virus (HTLV)-related endogenous sequence, HRES-1, encodes a 28-kDa protein: a possible autoantigen for HTLV-I gag-reactive autoantibodies. Proc Natl Acad Sci USA 1992; 89:1939-43.
70. Nakagawa K, Brusic V, McColl G, Harrison LC. Direct evidence for the expression of multiple endogenous retroviruses in the synovial compartment in rheumatoid arthritis. Arthritis Rheum 1997; 40:627-38.
71. Herve CA, Lugli EB, Brand A, Griffiths DJ, Venables PJW. Autoantibodies to human endogenous retrovirus-K are frequently detected in health and disease and react with multiple epitopes. Clin Exp Immunol 2002; 128:75-82.
72. Nelson PN, Westwood OMR, Soltys A et al. Characterisation of epitopes of pan-IgG/anti-G3m(u) and anti-Fc monoclonal antibodies. Immunol Lett 2003; 88:77-83.
73. Stransky G, Vernon J, Aicher WK, Moreland LW, Gay RE, Gay S. Virus-like particles in synovial fluids from patients with rheumatoid arthritis. Br J Rheumatol 1993; 32:1044-8.
74. Boller K, Janssen O, Schuldes H, Tonjes RR, Kurth R. Charactersation of the antibody response specific for the human endogenous retrovirus HTDV/HERV-K. J Virol 1997; 71:4581-8.
75. Seifarth W. Retrovirus-like particles released from human breast cancer cell line T47-D display type B- and C-related endogenous retroviral sequences. J Virol 1995; 69:6408-16.
76. Patience C, Simpson GR, Colletta AA, Welch HM, Weiss RA, Boyd MT. Human endogenous retrovirus expression and reverse transcriptase activity in the T47D mammary carcinoma cell line. J Virol 1996; 70:2654-7.
77. Towler EM, Gulnik SV, Bhat TN et al. Functional characerization of the protease of human endogenous retrovirus K10: can it complement HIV-1 protease? Biochemistry 1998; 37:17137-44.
78. An DS, Xie YM, Chen IS. Envelope gene of the human endogenous retrovirus HERV-W encodes a functional retrovirus envelope. J Virol 2001; 75:3488-9.
79. Stoye JP. The pathogenic potential of endogenous retroviruses: a sceptical view [Letter]. Trends Microbiol 1999; 7:430.